The EVOTECH® ECR Endoscope Cleaner and Reprocessor, a washer/disinfector, is indicated for use with high-level disinfectant CIDEX® OPA Concentrate and an enzymatic detergent (CIDEZYME GI) to achieve cleaning and high level disinfection of heat sensitive (>60 0C) semi-critical endoscopes. Manual cleaning of medical devices (endoscopes) is not required prior to placement in the EVOTECH® ECR Endoscope Cleaner & Reprocessor when selecting those cycles that contain a wash stage. (Manual cleaning of medical devices (endoscopes) is required when selecting the Disinfect only or Disinfect/Alcohol Flush Cycle.)

Device Description

The EVOTECH® ECR Endoscope Cleaner & Reprocessor is a two-basin washer/disinfector utilizing an enzymatic detergent and a concentrated high-level disinfectant, CIDEX OPA Concentrate Solution. Both the detergent and high-level disinfectant are diluted in the system to in-use concentrations. The EVOTECH® ECR Endoscope Cleaner & Reprocessor is capable of cleaning endoscopes that have not been manually cleaned prior to placing in the system.

AI/ML Overview

Here's an analysis of the acceptance criteria and study information for the EVOTECH® ECR Endoscope Cleaner & Reprocessor, based on the provided text:

Important Note: The provided text is a 510(k) summary, which focuses on demonstrating substantial equivalence to a predicate device rather than presenting a detailed, standalone clinical study report. Therefore, some information, particularly regarding specifics like effect sizes for human reader studies or detailed ground truth establishment for training sets, is not present because these types of studies (e.g., MRMC studies with human readers, or specific details about training data for an AI algorithm) are not relevant to the evaluation of a mechanical endoscope reprocessor. The device fundamentally automates a physical process, not an interpretive one involving human readers or AI algorithms for diagnostic purposes.

1. Table of Acceptance Criteria and Reported Device Performance

Test/Criteria Category	Acceptance Criteria	Reported Device Performance
High-Level Disinfection (Simulated Use)	A 6 Log$_{10}$ reduction of Mycobacterium terrae when flexible endoscopes, contaminated with Mycobacterium terrae and artificial soil, were exposed to CIDEX OPA Concentrate In Use solution without cleaning. Diluted CIDEX® OPA Concentrate at an MEC of 0.055% OPA concentration at 50°C is effective against Mycobacterium terrae in artificial soil.	A 6 Log$_{10}$ reduction of Mycobacterium terrae was achieved. The diluted CIDEX® OPA Concentrate at an MEC of 0.055% OPA concentration at 50°C was effective against Mycobacterium terrae in artificial soil.
Cleaning Efficacy (Simulated Use)	Residual soil (protein and total organic carbon - TOC) below a predefined limit of 8.5 ug/cm² after processing in the "wash only" cycle with contaminated endoscopes.	In all instances, the residuals (protein and TOC) were below the predefined limit of 8.5 ug/cm².
Cleaning Efficacy (Clinical In-Use, without manual pre-cleaning)	Processing in the EVOTECH® ECR Endoscope Cleaner & Reprocessor reduces residual protein and TOC in all channels and surfaces to less than predefined acceptance criteria.	Processing in the EVOTECH® ECR Endoscope Cleaner & Reprocessor reduced the residual protein and TOC in all channels and surfaces to less than the predefined acceptance criteria.
High-Level Disinfection (In-Use, Cleaned Endoscopes)	Not explicitly stated with a numerical criterion for this specific test, but implies effectiveness.	High-level disinfection of cleaned endoscopes was achieved (studied in K061889).
High-Level Disinfection (In-Use, Contaminated Endoscopes without manual/automated washing)	A >10$^6$ reduction in M. terrae after processing contaminated endoscopes through the disinfect cycle only.	There was a >10$^6$ reduction in M. terrae.
Quantitative Tuberculocidal Testing	Effectiveness of OPAC solution at 0.042% concentration in the presence of 5% fetal bovine serum organic soil load within 5 minutes at 50-52°C.	Effectiveness demonstrated for OPAC solution at 0.042% concentration in the presence of 5% fetal bovine serum organic soil load within 5 minutes at 50-52°C.
Sterility Testing (In-Use)	No growth after reprocessing clinically used endoscopes.	Sterility testing demonstrated no growth.
Biocompatibility	Residual OPA levels not likely to cause toxic effects in humans.	Analysis indicates that the level of OPA residual remaining on an endoscope is not likely to cause toxic effects in humans.
Material Compatibility	Minimal effect on test articles over extended periods of multiple disinfection cycles, similar to predicate device.	Multiple disinfection cycles over extended periods of time resulted in minimal effect on the test articles, similar to the predicate device.
Non-Inferiority (Automated Wash vs. Manual Wash)	Washing in the EVOTECH® ECR Endoscope Cleaner & Reprocessor determined to be non-inferior to washing following SGNA procedure.	Washing of endoscopes in the EVOTECH® ECR Endoscope Cleaner & Reprocessor was determined to be non-inferior to washing of endoscopes following the SGNA procedure.

The study that proves the device meets the acceptance criteria is detailed across the "SUMMARY OF NONCLINICAL TESTS" section of the 510(k) summary. These studies were conducted to support the substantial equivalence of the EVOTECH® ECR Endoscope Cleaner & Reprocessor. The summary references prior clearances (K040883, K061889, K991487) which contained data supporting various aspects of the device's performance.

Here's the breakdown of other requested information:

2. Sample Size Used for the Test Set and Data Provenance

High-Level Disinfection (Simulated Use): Not explicitly stated, but "flexible endoscopes" were contaminated and tested. The data provenance is implied to be laboratory testing rather than real-world clinical data from a specific country.
Cleaning Efficacy (Simulated Use): Not explicitly stated, but "endoscopes" were contaminated. The data provenance is implied to be laboratory testing.
Sterility Testing (In-Use): "Endoscopes used in a clinical environment" were reprocessed. The exact number of endoscopes is not specified. Data provenance is "clinical environment," but specific country or retrospective/prospective nature is not detailed.
Biocompatibility: "An endoscope reprocessed in the EVOTECH® ECR Endoscope Cleaner & Reprocessor" was evaluated. Sample size is at least one endoscope, potentially more for statistical relevance but not specified. Data provenance is laboratory testing.
Material Compatibility: "Test articles" (materials commonly used in medical devices) were evaluated. The number of test articles is not specified. Data provenance is laboratory testing.
Cleaning Efficacy (Clinical In-Use): "Endoscopes used in clinical procedures" were processed. Number not specified. Data provenance is "clinical procedures."
Non-Inferiority Trial (Automated Wash vs. Manual Wash): Not explicitly stated, but implies a comparative study involving multiple endoscopes and conditions. Data provenance is laboratory/simulated environment.
High-Level Disinfection (In-Use, Contaminated Endoscopes): "Endoscopes" were contaminated. Number not specified. Data provenance is laboratory testing.

Overall Data Provenance: The studies appear to be a mix of simulated-use (laboratory-based) and in-use (clinical environment) testing. The country of origin for the data is not specified in the provided text.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

This type of information is generally not applicable to the evaluation of an endoscope reprocessor. The "ground truth" for this device's performance is established through objective, measurable laboratory tests (e.g., microbial reduction counts, residual protein/TOC levels, chemical concentration measurements) performed by microbiologists, chemists, and engineers, rather than through expert interpretation of images or clinical cases. Therefore, there were no "experts" in the sense of radiologists or other clinicians establishing ground truth for a test set.

4. Adjudication Method for the Test Set

This is not applicable as the evaluation is based on objective measurements from laboratory and in-use tests, not subjective interpretations requiring adjudication.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done

No, an MRMC comparative effectiveness study was not done. This type of study is relevant for AI algorithms or diagnostic tools where human interpretation is involved. The EVOTECH® ECR is a mechanical cleaning and disinfecting device.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

This is not applicable. The EVOTECH® ECR is not an algorithm or AI system. Its performance evaluation is inherently "standalone" in the sense that its efficacy for cleaning and disinfection is measured directly as a mechanical system.

7. The Type of Ground Truth Used

The ground truth used for these studies was primarily:

Microbiological Counts: For disinfection studies, the ground truth was the initial and final counts of specific microorganisms (e.g., Mycobacterium terrae) on the endoscopes, determined through standard microbiological assays.
Chemical/Biochemical Assays: For cleaning efficacy, the ground truth was the quantified level of residual soil (e.g., protein, total organic carbon) on the endoscope surfaces, measured using analytical chemistry techniques.
Sterility Testing: For sterility, the ground truth was the absence of microbial growth based on culturing methods.
Chemical Concentration Measurement: For disinfectant effectiveness, the ground truth included verifying minimum effective concentrations of the disinfectant.

8. The Sample Size for the Training Set

This information is not applicable because the device is a mechanical reprocessor, not an AI or machine learning algorithm that requires a "training set."

9. How the Ground Truth for the Training Set was Established

This information is not applicable for the reasons stated above.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

December 22,2014

Advanced Sterilization Products Mr. Reuben Lawson Sr. Manager, Regulatory Affairs 33 Technology Drive Irvine, California 92618

Re: K140977

Trade/Device Name: EVOTECH® ECR Endoscope Cleaner & Reprocessor Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscopes and Accessories Regulatory Class: II Product Code: FEB Dated: November 24, 2014 Received: November 25, 2014

Dear Mr. Lawson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Page 2 - Mr. Lawson

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Susan Runno DDS, MA

Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

{2}------------------------------------------------

Indications for Use

510(k) Number (if known): K140977

Device Name: EVOTECH® ECR Endoscope Cleaner and Reprocessor

The EVOTECH® ECR Endoscope Cleaner and Reprocessor, a washer/disinfector, is indicated for use with high-level disinfectant CIDEX® OPA Concentrate and an enzymatic detergent (CIDEZYME GI) to achieve cleaning and high level disinfection of heat sensitive (>60 0C) semi-critical endoscopes. Manual cleaning of medical devices (endoscopes) is not required prior to placement in the EVOTECH® ECR System when selecting those cycles that contain a wash stage. (Manual cleaning of medical devices (endoscopes) is required when selecting the Disinfect only or Disinfect/Alcohol Flush Cycle.)

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use X (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of 1

{3}------------------------------------------------

510(k) Summary

Applicant's Name, Address, Telephone, FAX, Contact Person

Advanced Sterilization Products, Division of Ethicon, Inc. a Johnson & Johnson company 33 Technology Drive Irvine, CA 92618

Contact Person

Reuben Lawson Senior Manager, Regulatory Affairs Tel: (949) 789-8545 Fax: (949) 789-3900

SUMMARY DATE

December 18, 2014

1. CLASSIFICATION, COMMON OR USUAL NAME, DEVICE NAME

Trade Name:	EVOTECH® ECR Endoscope Cleaner &Reprocessor
Common/Usual Name:	Endoscope Cleaner & Reprocessor
Classification Name:	Endoscope & Accessories (21 CFR 876.1500Product Code FEB)
Product Classification:	Class II

2. PREDICATE DEVICES

. EVOTECH® Integrated Washer Disinfector (K082392, cleared November 13, 2008)

3. DESCRIPTION OF DEVICE

{4}------------------------------------------------

Endoscopes that have been qualified for processing in the EVOTECH® ECR Endoscope Cleaner & Reprocessor must go through manual bedside pre-cleaning according to SGNA and facility guidelines prior to being placed in the EVOTECH® ECR Endoscope Cleaner & Reprocessor for automated cleaning and/or high level disinfection. If automatic cleaning is not available or desired for the device by the user, the endoscope must also be manually cleaned by the user prior to being placed in the EVOTECH® ECR Endoscope Cleaner & Reprocessor.

After the endoscopes are connected to the EVOTECH® ECR Endoscope Cleaner & Reprocessor, the detergent is sprayed onto the surface of the device, and pumped through the lumens of the device, at sufficient pressure levels to remove any soil present on or in the device.

The disinfectant is then mixed with incoming water, which is monitored to ensure that the water temperature is then sprayed onto the surface of the device, and pumped through the lumens of the device, at sufficient time and temperature to achieve high level disinfection of any microorganisms. The temperature is monitored to ensure operating parameters of 50°C are met. A sample of the diluted CIDEX OPA Concentrate solution is extracted to ensure minimum effective concentration levels have been achieved. Following disinfection, the endoscopes are rinsed by the machine and air pumped through the lumens to facilitate drying of the endoscope. If selected by the user, an alcohol flush cycle may also be run to facilitate drying of the endoscope. The endoscope may then be removed, dried and used. The onboard printer generates a cycle printout summarizing the cycle results for the user's records.

The machine has built in safety features which cancel the cycle and notify the user if parameters are not met. These notifications, their causes, and next steps for the user. are defined in the EVOTECH® ECR Endoscope Cleaner & Reprocessor User Guide.

4. INTENDED USE

The EVOTECH® ECR Endoscope Cleaner & Reprocessor is designed to automatically clean and high-level disinfect flexible, submersible video or fiber-optic endoscopes. High-level disinfection requires that the system be used with CIDEX® OPA Concentrate Solution

5. INDICATIONS FOR USE

{5}------------------------------------------------

stage. (Manual cleaning of medical devices (endoscopes) is required when selecting the Disinfect only or Disinfect/Alcohol Flush Cycle.)

6. SUMMARY OF TECHNOLOGICAL CHARACTERISTICS

The EVOTECH® ECR Endoscope Cleaner & Reprocessor that is this subject of this submission is the same model as the predicate cleared in K082392. The comparison between the predicate device and the EVOTECH® ECR Endoscope Cleaner & Reprocessor shows the device to meet the definition of substantially equivalence because:

. the devices have the same intended use
and the same technological characteristics ●

{6}------------------------------------------------

Feature	Predicate DeviceEVOTECH® ECR EndoscopeCleaner and Reprocessor	New DeviceEVOTECH® ECR EndoscopeCleaner and Reprocessor
Intended Use	The EVOTECH® ECR EndoscopeCleaner and Reprocessor is intendedfor use as a washer / disinfector forcleaning and high level disinfection offlexible endoscopes that do not contactnormally sterile areas of the body.	Same as Predicate Device
Indications for Use	The EVOTECH® ECR EndoscopeCleaner and Reprocessor, awasher/disinfector, indicated is for usewith high-level disinfectant CIDEX®OPA Concentrate and an enzymaticdetergent (CIDEZYME GI) to achievecleaning and high level disinfection ofheat sensitive (>60 0C) semi-criticalendoscopes. Manual cleaning ofmedical devices (endoscopes) is notrequired prior to placement in theEVOTECH System when selectingthose cycles that contain a wash stage.(Manual cleaning of medical devices(endoscopes) is required when selectingthe Disinfect only or Disinfect/AlcoholFlush Cycle.)	Same as Predicate Device
Disinfectant Used	CIDEX OPA Concentrate Solution(Single Use)	Same as Predicate Device
Identification ofmaterials that comeinto contact withfluid pathways	Endoscopes and materials comprisingthe EVOTECH® ECR EndoscopeCleaner and Reprocessor: powdercoated aluminum glass, stainless steel,polyethylene, Neoprene,polypropylene, polyamide, Ultem,polycarbonate, polypropylene, CIDEXOPA Concentrate (in-use solution)	Same as Predicate Device
Process Monitors	In line optical monitor for disinfectantconcentration, spray arm rotationsensor, detergent dispensing monitor.Same as predicate device with theaddition of an endoscope connectiontest as part of the leak test.	Same as Predicate Device
Process Parameters	Temperature of rinse water has beenincreased to 49.5°C (from 45°C).Flow rate in all channels has increaseddue to the use of larger peristaltic pump	Same as Predicate Device
Software /firmware controls	Software controlled	Same as Predicate Device
Cycle comparisons	Cleans endoscopes and achieves high-level disinfection in 5 minutes at aminimum of 50°C.	Same as Predicate Device
Channels	Six channels for cleaning endoscopeswith up to six channels.	Same as Predicate Device
Accessories	CIDEX® OPA Concentrate high leveldisinfectant and an enzymatic detergent(CIDEZYME GI) for cleaning medicalinstruments	Same as Predicate Device

{7}------------------------------------------------

7. SUMMARY OF NONCLINICAL TESTS

The EVOTECH® ECR Endoscope Cleaner & Reprocessor is a washer/disinfector for use with an enzymatic detergent and the high-level disinfectant CIDEX® OPA Concentrate Solution at 50° with an exposure time of 5 min to achieve cleaning and high-level disinfection of flexible endoscopes.

The EVOTECH® ECR Endoscope Cleaner & Reprocessor was tested in K040883 using the standard array of tests defined in the FDA Guidance on Premarket Notification [510(k)] Submission for Automated Endoscope Washers, Washer / Disinfectors, and Disinfectors Intended for Use in Health Care Facilities, August, 1993.

For simulated use testing, the high level disinfectant indicated for use with the EVOTECH® ECR Endoscope Cleaner & Reprocessor was tested for efficacy in a simulated use environment. A 6 Log10 reduction of Mycobacterium terrae was achieved when flexible endoscopes, contaminated with Mycobacterium terrae and artificial soil and were exposed to CIDEX OPA Concentrate In Use solution without cleaning. The diluted CIDEX® OPA Concentrate at an MEC of 0.055% OPA concentration at 50°C is effective against Mycobacterium terrae in artificial soil.

For in use testing, endoscopes used in a clinical environment were reprocessed in the EVOTECH® ECR Endoscope Cleaner & Reprocessor without manual cleaning. Sterility testing demonstrated no growth.

For biocompatibility, an endoscope reprocessed in the EVOTECH® ECR Endoscope Cleaner & Reprocessor was evaluated for residue levels. The analysis indicates that the level of OPA residual remaining on an endoscope is not likely to cause toxic effects in humans.

For material compatibility, the EVOTECH® ECR Endoscope Cleaner & Reprocessor using CIDEX OPA Concentrate In-Use solution was evaluated for its effect on materials commonly used in medical devices. Multiple disinfection cycles over extended periods of time resulted in minimal effect on the test articles. The effects

{8}------------------------------------------------

seen were similar to those seen with the predicate device for the high level disinfectant - CIDEX OPA Solution K991487.

The EVOTECH® ECR Endoscope Cleaner & Reprocessor was further tested in K061889 to determine its ability to high level disinfect and clean endoscopes. Both simulated use and in-use studies were completed. In both instances, endoscopes were contaminated and then processed in the "wash only" cycle in the EVOTECH® ECR Endoscope Cleaner & Reprocessor. Residual soil was quantified for both protein and total organic carbon (TOC). In all instances the residuals were below the predefined limit of 8.5ug/cm².

Additionally, because the wash cycle is intended to eliminate the need for manual cleaning. studies were completed comparing the residual soil after manual cleaning according to the procedures of the Society for Gastroenterology Nurses and Associates (SGNA) and cleaning in the EVOTECH® ECR Endoscope Cleaner & Reprocessor. In a non-inferiority trial, the washing of endoscopes in the EVOTECH® ECR Endoscope Cleaner & Reprocessor was determined to be noninferior to washing of endoscopes following the SGNA procedure.

Endoscopes used in clinical procedures were processed through the "wash only" cycle of the EVOTECH® ECR Endoscope Cleaner & Reprocessor and then extracted for residual organic material. Processing in the EVOTECH® ECR Endoscope Cleaner & Reprocessor reduced the residual protein and TOC in all channels and surfaces to less than the predefined acceptance criteria, indicating that the EVOTECH® ECR Endoscope Cleaner & Reprocessor can clean clinically used endoscopes.

High-level disinfection of cleaned endoscopes was achieved. Endoscopes were contaminated with Mycobacterium terrae imbedded in soil. Soil was inoculated in channels and on the surfaces of endoscopes so that each endoscopes contained ≥8.5ug/cm² protein with >10' cfu/mL M. terrae. Endoscopes were disinfected in the EVOTECH® ECR Endoscope Cleaner & Reprocessor without manual or automated washing. After processing the contaminated endoscopes through the disinfect cycle only in the EVOTECH® ECR Endoscope Cleaner & Reprocessor, there was a >10° reduction in M. terrae.

Further high level disinfection testing and quantitative tuberculocidal testing have been completed for this submission demonstrating effectiveness of the OPAC solution at 0.042% concentration in the presence of 5% fetal bovine serum organic soil load within 5 minutes at 50-52°C using CIDEX OPA-C solution.

8. OVERALL PERFORMANCE CONCLUSIONS

Data presented in this submission indicate that the EVOTECH® ECR Endoscope Cleaner & Reprocessor is substantially equivalent to the Predicate Device.

{9}------------------------------------------------

Regulation Number and Section

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.